Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian survey

Abstract

BackgroundDuring the 2009 influenza A/H1N1v pandemic, children were identified as a specific "at risk" group. We conducted a multicentric study to describe pattern of influenza A/H1N1v infection among hospitalized children in Brussels, Belgium.MethodsFrom July 1, 2009, to January 31, 2010, we collected epidemiological and clinical data of all proven (positive H1N1v PCR) and probable (positive influenza A antigen or culture) pediatric cases of influenza A/H1N1v infections, hospitalized in four tertiary centers.ResultsDuring the epidemic period, an excess of 18% of pediatric outpatients and emergency department visits was registered. 215 children were hospitalized with proven/probable influenza A/H1N1v infection. Median age was 31 months. 47% had ≥ 1 comorbid conditions. Febrile respiratory illness was the most common presentation. 36% presented with initial gastrointestinal symptoms and 10% with neurological manifestations. 34% had pneumonia. Only 24% of the patients received oseltamivir but 57% received antibiotics. 10% of children were admitted to PICU, seven of whom with ARDS. Case fatality-rate was 5/215 (2%), concerning only children suffering from chronic neurological disorders. Children over 2 years of age showed a higher propensity to be admitted to PICU (16% vs 1%, p = 0.002) and a higher mortality rate (4% vs 0%, p = 0.06). Infants less than 3 months old showed a milder course of infection, with few respiratory and neurological complications.ConclusionAlthough influenza A/H1N1v infections were generally self-limited, pediatric burden of disease was significant. Compared to other countries experiencing different health care systems, our Belgian cohort was younger and received less frequently antiviral therapy; disease course and mortality were however similar.

Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data

“…The percentages of missing data were smaller for the deaths than the survivors (0.4% vs. 36% for time to death/discharge for example), suggesting that data collection was more thorough for patients who died. 210 Poeppl 2011 198 Blumental 2011 202 Yung 2011 195 Altmann 2011 185 Enstone 2011 192 del Rosal 2011 205 Nguyen-Van-Tam 2010 186 Thompson 2011 188 Miranda-Choque 2011 197 Yokota 2011 200 Moretti 2011 208 Yang 2010 191 Mickienė 2011 Results show that when the time-dependent nature of treatment is taken into account appropriately the treatment effects change direction, although none of the results is statistically significant. Adjusting for potential confounders and imputing missing data made little difference to the results.…”

Influenza in hospitalized children in Ireland in the pandemic period and the 2010/2011 season: risk factors for paediatric intensive-care-unit admission

“…Other studies comparing pandemic influenza with previous seasons have found that children admitted with influenza A(H1N1)pdm09 were older than those admitted with seasonal influenza A in the years prior to the pandemic [3,7,8,26,[30][31][32][33]. Apart from age, no other differences were found in hospitalized and PICU cases during the pandemic period and the 2010/2011 season.…”

Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations

“…A German observational study reported comorbidities (e.g., chronic respiratory or cardiac disease; neurodevelopmental disorder) in 75% of intensive care unit pediatric admissions due to pandemic influenza (H1N1) [7]. In a Belgian multicenter survey, 47% of children hospitalized with pandemic influenza had similar comorbidities [8].…”

“…7 DTaP-IPV administered. 8 DTaP is administered. 9 DTaP is administered (reduced diphtheria and pertussis dose).…”